Amitava Moulick, MSc., Ph.D.
Assistant Professor, Faculty of Pharmacy
| web: | https://www.muni.cz/en/people/254786-amitava-moulick |
|---|
| social and academic networks: |
|---|
NanoBioInteractions Lab
Advancing nanomaterial discovery for next-generation therapeutics and biomedical applications
NanoBioInteractions Lab, led by Dr. Amitava Moulick, focuses on the rational design and development of advanced nanomaterials for biomedical applications, with particular emphasis on antibacterial nanotherapeutics targeting multidrug‑resistant pathogens.
The lab investigates how engineered nanomaterials interact with biological systems at the molecular, cellular, microbial, and tissue levels to enable next‑generation therapeutic and diagnostic platforms.
Our research integrates synthetic chemistry, nanomaterial engineering, molecular biology, microbiology, peptide engineering, pharmaceutical sciences, and mechanistic studies of nanomaterial–biological interactions.
Through this interdisciplinary approach, we aim to advance the fundamental understanding of how nanomaterials influence biological processes and translate this knowledge into innovative therapeutic and diagnostic technologies.
Nanomaterial Engineering
Rational design and synthesis of advanced nanostructures tailored for therapeutic, diagnostic, and translational biomedical applications.
Rational design and synthesis of advanced nanostructures tailored for therapeutic, diagnostic, and translational biomedical applications.
Mechanistic Studies
Elucidation of molecular mechanisms underlying nanomaterial activity and their interactions with biological systems.
Antibacterial Nanotherapeutics
Development of nanomaterials designed to combat multidrug‑resistant bacterial pathogens and support innovative therapeutic strategies.
Nanomaterial–Biological Interactions
Investigation of how nanomaterials interact with cells, microbes, and tissues to understand their biological effects and mechanisms of action.
Peptide-Based Nanoplatforms
Integration of peptide components into nanomaterials to enhance targeting, stability, and biological activity.
Group Leader
Amitava Moulick, MSc., Ph.D.
Asistant Professor, Faculty of Pharmacy, Masaryk University
Dr. Moulick specializes in antibacterial nanotherapeutics and the mechanistic study of nanomaterial–biological interactions, with a strong focus on translational biomedical applications.
Team Members
Internal Collaborator:
Ing. Pavel Bobáľ, CSc. ,Head, Department of Chemical Drugs, Faculty of Pharmacy, Masaryk University
External Collaborators:
- Harvard University, USA
- University of Pittsburgh, USA
- Kansas State University, USA
- UAB Barcelona, Spain
- Czech Academy of Sciences, Czech Republic
- International Clinical Research Center (ICRC), Czech Republic
- Central European Institute of Technology (CEITEC), Czech Republic
- Polish Academy of Sciences, Poland
- Indian Institutes of Technology (IIT), India
- University of Calcutta, India
NanoBioInteractions Lab was awarded the Seal of Excellence for a proposal submitted to the Marie Skłodowska-Curie Actions Fellowship programme, with Dr. Soumalaya Roy as the candidate.
Get in Touch
Interested in research collaboration, scientific discussion, or learning more about our work?
Contact us
email: moulicka@pharm.muni.cz
Department of Chemical Drugs
Faculty of Pharmacy
Masaryk University
Studentská 832/13
625 00 Brno-Bohunice